Daniel MacLachlan - 19 Dec 2025 Form 4 Insider Report for Red Violet, Inc. (RDVT)

Reporting relationship: Chief Financial Officer
Issuer ticker: RDVT
Reported as of: 19 Dec 2025
Net transaction value: -$293,150
SEC form: 4
Accepted by SEC: 22 Dec 2025, 18:55:41 UTC
Prior SEC filing: 05 Dec 2025
Next SEC filing: 01 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Daniel MacLachlan

Key filing fact

Daniel MacLachlan filed Form 4 for Red Violet, Inc. (RDVT) on 22 Dec 2025.

Key facts

This page summarizes Daniel MacLachlan's Form 4 filing for Red Violet, Inc. (RDVT).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 22 Dec 2025, 18:55.

Change

Previous filing in this sequence was filed on 05 Dec 2025.
Current net transaction value: -$293,150.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001640723 Primary reporting owner

MacLachlan Daniel

Relationship: Chief Financial Officer
Address: C/O RED VIOLET, INC., 2650 N. MILITARY TRAIL, SUITE 300, BOCA RATON
Signature: /s/ Daniel MacLachlan
Signature date: 22 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RDVT transaction

Common Stock

Tax liability

Transaction value: $293,150
Shares: -5,247
Change %: -1.5%
Price: $55.87
Shares after: 351,916
Date: 19 Dec 2025
Ownership: Direct
Footnotes: F1, F2, F3

RDVT transaction

Common Stock

Award

Transaction value
Shares: +18,520
Change %: +5.3%
Price
Shares after: 370,436
Date: 19 Dec 2025
Ownership: Direct
Footnotes: F2, F3, F4

RDVT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 466
Date: 19 Dec 2025
Ownership: Held by IRA

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the disposition to issuer for tax obligations upon the vesting of the second tranche of 13,333 restricted stock units (RSUs) of the grant originally approved by the Company's Compensation Committee on November 30, 2023.

Footnote F2

Includes 13,333 RSUs originally granted on November 30, 2023, convertible into common stock of the issuer on a one-for-one basis, which vests on December 1, 2026, subject to accelerated vesting under certain circumstances.

Footnote F3

Includes 21,000 RSUs originally granted on November 4, 2024, convertible into common stock of the issuer on a one-for-one basis, which vests in two equal installments on each of November 1, 2026 and November 1, 2027, subject to accelerated vesting under certain circumstances.

Footnote F4

On December 19, 2025, the reporting person received a grant of 18,520 RSUs convertible into common stock of the issuer on a one-for-one basis, which vests in three equal installments on each of December 1, 2026, December 1, 2027, and December 1, 2028, subject to accelerated vesting under certain circumstances.